http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102275326-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-433 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-433 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
filingDate | 2014-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-102275326-B1 |
titleOfInvention | Bisulfate of janus kinase (jak) inhibitor and preparation method therefor |
abstract | The present invention relates to bisulfates of Janus kinase (JAK) inhibitors and methods for their preparation. More specifically, the present invention relates to (3aR,5s,6aS)-N-(3-methoxy-1,2,4-thiadiazole-5-group)-5-(methyl(7H- pyrrolo[2,3-d]pyrimidin-4-yl)amino)hexahydrocyclopenta[c]pyrrole-2(1H)-formamide bisulfate, a process for its preparation, and uses thereof. The bisulfate represented by the following formula (I) can be well used as a Janus kinase (JAK) inhibitor in clinical studies, and thus can be well used for the treatment of rheumatism or rheumatoid arthritis. [Formula I] |
priorityDate | 2013-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.